Chemoinformaics analysis of BETA-HOMOCHELIDONINE
| Molecular Weight | 369.417 | nRot | 2 |
| Heavy Atom Molecular Weight | 346.233 | nRig | 25 |
| Exact Molecular Weight | 369.158 | nRing | 4 |
| Solubility: LogS | -4.098 | nHRing | 2 |
| Solubility: LogP | 2.911 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 12 |
| nHA | 6 | APOL | 55.5162 |
| nHD | 0 | BPOL | 32.5958 |
| QED | 0.811 |
| Synth | 3.017 |
| Natural Product Likeliness | 0.763 |
| NR-PPAR-gamma | 0.012 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.027 |
| Pgp-sub | 0.169 |
| HIA | 0.002 |
| CACO-2 | -4.923 |
| MDCK | 0.0000255 |
| BBB | 0.994 |
| PPB | 0.846673 |
| VDSS | 1.977 |
| FU | 0.0869783 |
| CYP1A2-inh | 0.821 |
| CYP1A2-sub | 0.939 |
| CYP2c19-inh | 0.632 |
| CYP2c19-sub | 0.934 |
| CYP2c9-inh | 0.036 |
| CYP2c9-sub | 0.816 |
| CYP2d6-inh | 0.96 |
| CYP2d6-sub | 0.919 |
| CYP3a4-inh | 0.939 |
| CYP3a4-sub | 0.913 |
| CL | 14.498 |
| T12 | 0.4 |
| hERG | 0.648 |
| Ames | 0.083 |
| ROA | 0.542 |
| SkinSen | 0.183 |
| Carcinogencity | 0.669 |
| EI | 0.008 |
| Respiratory | 0.942 |
| NR-Aromatase | 0.231 |
| Antiviral | No |
| Prediction | 0.663655 |